Autoantibody to the Leucine Zipper Region of 52 kDa Ro/SSA Binds Native 60 kDa Ro/SSA: Identification of a Tertiary Epitope with Components from 60 kDa Ro/SSA and 52 kDa Ro/SSA

Anti‐Ro (or SSA) is found in the sera of patients with autoimmune rheumatic illnesses. All patients with anti‐Ro defined by precipitation bind a 60 000 Da antigen (60 kDa Ro), whereas some patients also bind a 52 000 Da molecule (52 kDa Ro). In general, antibody binding is directed against native 60 kDa Ro and denatured 52 kDa Ro. The mechanism by which anti‐52 kDa Ro arises in the setting of anti‐60 kDa Ro is unknown. Conflicting data exist as to the existence of a physical interaction between the two proteins in cells and as to cross‐reacting antibodies. Antibodies were affinity purified from a peptide within the leucine zipper region of 52 kDa Ro. These purified antibodies binding the 197–207 peptide from 52 kDa Ro (anti‐52LZ) bound native 60 kDa Ro as well as denatured 52 kDa Ro. In addition, anti‐52LZ also bound up to four regions from the sequence of 60 kDa Ro and a single conformational epitope of 60 kDa Ro. Thus, these primary sites represent components of the tertiary epitope. We hypothesized that if this was the case, these peptides making up a tertiary epitope would show molecular interaction. In fact, peptides from 60 kDa Ro have a molecular interaction with the 52 kDa Ro peptide as well as full‐length 52 kDa Ro when assessed by surface plasmon resonance. The leucine‐zipper region peptide from 52 kDa Ro bound three of the four peptides from 60 kDa Ro. These data suggest that these two molecular species, 60 and 52 kDa Ro, form a conformational epitope. This relationship may explain why anti‐52 kDa Ro is found in association with anti‐60 kDa Ro.

[1]  Stephen M. Mount,et al.  Are snRNPs involved in splicing? , 1980, Nature.

[2]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[3]  K. Moore,et al.  Association of neutropenia in systemic lupus erythematosus (SLE) with anti‐Ro and binding of an immunologically cross‐reactive neutrophil membrane antigen , 2000, Clinical and experimental immunology.

[4]  D. J. Van Horn,et al.  A misfolded form of 5S rRNA is complexed with the Ro and La autoantigens. , 1996, RNA.

[5]  M. B. Frank,et al.  Epitope mapping of the 52‐kD Ro/SSA autoantigen , 1994, Clinical and experimental immunology.

[6]  S. Lapointe,et al.  Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd Ro/SS-A protein. , 1991, Arthritis and rheumatism.

[7]  J. Harley,et al.  Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody. , 1984, The Journal of clinical investigation.

[8]  D. McCauliffe,et al.  Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins. , 1994, The Journal of rheumatology.

[9]  J A Hardin,et al.  Induction of autoreactive B cells allows priming of autoreactive T cells , 1991, The Journal of experimental medicine.

[10]  K. Tung,et al.  Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida. , 1992, The Journal of clinical investigation.

[11]  N. Ringertz,et al.  Identification of antigenic regions of the human 52kD Ro/SS-A protein recognized by patient sera. , 1994, Journal of autoimmunity.

[12]  F. Tashiro,et al.  Autoepitopes of the 52-kd SS-A/Ro molecule. , 1995, Arthritis and rheumatism.

[13]  J. Harley,et al.  Molecular analysis of the 60-kDa human Ro ribonucleoprotein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Winchester,et al.  Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. , 1990, Journal of immunological methods.

[15]  K. Sullivan,et al.  A 52-kD protein is a novel component of the SS-A/Ro antigenic particle , 1988, The Journal of experimental medicine.

[16]  M. Mattioli,et al.  Correlation of a precipitin reaction to an RNAprotein antigen and a low prevalence of nephritis in patients with systemic lupus erythematosus. , 1972, The New England journal of medicine.

[17]  G. Pruijn,et al.  Anti‐Ro52 antibodies frequently co‐occur with anti‐Jo‐1 antibodies in sera from patients with idiopathic inflammatory myopathy , 1997, Clinical and experimental immunology.

[18]  G. Pruijn,et al.  Ro ribonucleoprotein assembly in vitro. Identification of RNA-protein and protein-protein interactions. , 1992, Journal of molecular biology.

[19]  J. Harley,et al.  Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity. , 1996, Journal of immunology.

[20]  D. Isenberg,et al.  Epitope mapping with synthetic peptides of 52‐kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera , 1994, Clinical and experimental immunology.

[21]  E. Sercarz,et al.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.

[22]  J. Harley,et al.  Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. , 1999, Arthritis and rheumatism.

[23]  J. Tam,et al.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Harley,et al.  Human Anti‐Ro Autoantibodies Bind Peptides Accessible to the Surface of the Native Ro Autoantigen , 1995, Scandinavian journal of immunology.

[25]  G. Pruijn,et al.  Epitope specificity determines the ability of anti-Ro52 autoantibodies to precipitate Ro ribonucleoprotein particles. , 1994, Journal of immunology.

[26]  S. Wolin,et al.  A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors. , 1994, Genes & development.

[27]  J. Harley,et al.  Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Harley,et al.  A MODEL FOR DISEASE HETEROGENEITY IN SYSTEMIC LUPUS ERYTHEMATOSUS: Relationships Between Histocompatibility Antigens, Autoantibodies, and Lymphopenia or Renal Disease , 1989, Arthritis and rheumatism.

[29]  M. Reichlin,et al.  Autoantibodies to the Ro/SSA antigen are conformation dependent. I: Anti-60 kD antibodies are mainly directed to the native protein; anti-52 kD antibodies are mainly directed to the denatured protein. , 1992, Autoimmunity.

[30]  D. Isenberg,et al.  The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. , 1999, Journal of autoimmunity.

[31]  M. Reichlin,et al.  Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II: Antibodies to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule. , 1992, Autoimmunity.

[32]  M. Reichlin,et al.  Heterogeneity of the Ro/SSA antigen and autoanti‐Ro/SSA response: evidence of the four antigenically distinct forms , 1990, Clinical and experimental immunology.

[33]  J. Harley,et al.  Anti‐Ro fine specificity defined by multiple antigenic peptides identifies components of tertiary epitopes , 1997, Clinical and experimental immunology.

[34]  J. Reveille,et al.  Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome. , 1994, Journal of immunology.

[35]  J. Harley,et al.  Protein-protein interaction of the Ro-ribonucleoprotein particle using multiple antigenic peptides. , 1999, Molecular immunology.

[36]  G. Pruijn,et al.  Sera from patients with rheumatic diseases recognize different epitope regions on the 52‐kD Ro/SS‐A protein , 1993, Clinical and experimental immunology.

[37]  J. McCluskey,et al.  Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Ménard,et al.  Purification of antigenically intact Ro ribonucleoproteins; biochemical and Immunological evidence that the 52‐kD protein is not a Ro protein , 1995, Clinical and experimental immunology.

[39]  J. Harley,et al.  Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity , 1995, The Journal of experimental medicine.

[40]  J. Harley,et al.  Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus. , 1992, Rheumatic diseases clinics of North America.

[41]  J. van Egmond,et al.  Presence of anti-La(SS-B) is associated with binding to the 13-kD carboxyl terminus of 60-kD Ro(SS-A) in systemic lupus erythematosus. , 1993, The Journal of investigative dermatology.

[42]  J. McCluskey,et al.  The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. , 1996, Journal of immunology.

[43]  J. Harley,et al.  A subset of hY RNAs is associated with erythrocyte Ro ribonucleoproteins. , 1990, The EMBO journal.

[44]  M. B. Frank,et al.  Expression and DNA binding of the human 52 kDa Ro/SSA autoantigen. , 1995, The Biochemical journal.

[45]  K. Sullivan,et al.  Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen. , 1989, The Journal of clinical investigation.

[46]  J. A. Burch,et al.  Specificity of autoantibodies for recombinant 60-kd and 52-kd Ro autoantigens. , 1994, Arthritis and rheumatism.